Results 141 to 150 of about 1,341,475 (356)

Breast Conserving Therapy for Early Breast Cancer after Augmentation Mammoplasty: A Case Report.

, 1998
Daisuke Takata, Yuichi Iino, Jun Horiguchi, Hiroshi Nagaoka, Hiroyuki Takei, Masahiro Nagasawa, Michio Maemura, Y Horii, Hiroshi Matsumoto, Miho Yoshida, Kiyomi Igarashi, Takao Yokoe, Tetsunari Oyama, Takeshi Nakajima, Yasuo Morishita   +14 more
openalex   +2 more sources

Endoscopic transaxillary breast augmentation [PDF]

, 2004
Carl Troilius
openalex   +1 more source

Targeting Glutamine Metabolism Transporter SLC25A22 Enhances CD8+ T‐Cell Function and Anti‐PD‐1 Therapy Efficacy in Cervical Squamous Cell Carcinoma: Integrated Metabolomics, Transcriptomics and T‐Cell‐Incorporated Tumor Organoid Studies

Advanced Science, EarlyView.
Through metabolomic and transcriptomic analyses, a glutamine‐enriched, immunosuppressive microenvironment is identified in cervical squamous cell carcinoma (CSCC), highlighting the glutamine transporter SLC25A22 as a key regulator of glutamine metabolism, immune checkpoint activation, and CD8+ T‐cell cytotoxicity.
Tingting Ren, Junjun Qiu, Fanghua Chen, Qian Jiang, Qinqin Liu, Tong Wu, Hua Jiang, Keqin Hua   +7 more
wiley   +1 more source

Chronic haematoma as a late complication of cosmetic breast augmentation

, 2000
Awen Iorwerth, R. Cochrane, David Webster   +2 more
openalex   +1 more source

Augmentation of Tissue Transglutaminase Expression and Activation by Epidermal Growth Factor Inhibit Doxorubicin-induced Apoptosis in Human Breast Cancer Cells [PDF]

, 2004
Marc A. Antonyak, Allison M. Miller, Jaclyn M. Jansen, Jason E. Boehm, Cheryl E. Balkman, Joseph J. Wakshlag, Rodney L. Page, Richard A. Cerione   +7 more
openalex   +1 more source

Novel Quaternary Ammonium Salt‐Linked STING Agonist Antibody‐Drug Conjugate: Synergistic Activation of Tumor Immunity with Mitigated Off‐Target Toxicity

Advanced Science, EarlyView.
Novel quaternary ammonium salt‐linked STING agonist ADC demonstrates high potency, stability, enhanced solubility, and reduced off‐target toxicity, potently activating the STING pathway in the tumor microenvironment through the synergistic action of the Fab and Fc regions of antibodies (activity switch‐on) while exhibiting ≈20 fold lower activity in ...
Yu Long, Borui Tang, Fei Xie, Lianqi Liu, Yangyihua Zhou, Jingwen Dong, Jianfeng Wang, Cuicui Sun, Yuting Wang, Ruoqi Li, Na Zhang, Liping Li, Longlong Luo, Junhai Xiao, Wu Zhong, Dian Xiao, Hongbin Deng, Xinbo Zhou   +17 more
wiley   +1 more source

Breast augmentation with periareolar mastopexy

, 2000
Scott L. Spear, Steven P. Davison
openalex   +1 more source

Breast augmentation is unlikely to affect cancer identificaton [PDF]

, 2004

openalex   +1 more source

Combining PIM‐2 and PARP1 Inhibitors Induces MICA Expression on Multiple Myeloma Cells to Activate NK Cells through NKG2D Binding

Advanced Science, EarlyView.
The findings suggest that the combination of PIM‐2 and PARP1 inhibitors can induce MICA expression on MM cells, thereby activating NK cells through NKG2D binding. This process may restore NK cell function and serve as a potential therapeutic approach for MM patients. Abstract While immunogenic death in tumor cells activates specific anti‐tumor T cells,
Zhaoyun Liu, Wenhui Lei, Xiaohan Liu, Hui Liu, Kai Ding, Jia Song, Rong Fu   +6 more
wiley   +1 more source

Breast augmentation in the patient with von Willebrand disease [PDF]

, 2006
Sai S. Ramasastry, Yuxiao Chen, D MORRIS
openalex   +1 more source